Page 93 - 北京京煤集团总医院第十一届·2023学术年会论文集
P. 93
北京京煤集团总医院 第十一届·2023 学术年会论文集
参考文献
[1] 胡浩, 张胜利, 邵敏. 脓毒症患者外周血单核细胞 miR-147b 的表达及其与病情严重程度
和预后的关系[J]. 广东医学, 2023, 44(2): 182-187. 10.13820/j.cnki.gdyx.20222160
[2] Ishaque S, Famularo S T, 3rd, Saleem A F, et al. Biomarker-Based Risk Stratification in Pediatric
Sepsis From a Low-Middle Income Country[J]. Pediatr Crit Care Med, 2023, 24(7): 563-573.
10.1097/pcc.0000000000003244
[3] 汪浪, 张智琪, 沈雪, et al. 老年脓毒症患者临床特征及预后影响因素[J]. 中国感染控制
杂志, 2022, 21(4): 377-383. 10.12138/j.issn.1671-9638.20222021
[4] Jiang S, Wang Y, Chen L, et al. PAI-1 genetic polymorphisms influence septic patients' outcomes
by regulating neutrophil activity[J]. Chin Med J (Engl), 2023, 136(16): 1959-1966.
10.1097/cm9.0000000000002316
[5] Mizugaki A, Wada T, Tsuchida T, et al. Association of Histones With Coagulofibrinolytic
Responses and Organ Dysfunction in Adult Post-cardiac Arrest Syndrome[J]. Front Cardiovasc Med,
2022, 9: 885406. 10.1038/s41598-023-30305-810.3389/fcvm.2022.885406
[6] Tipoe T L, Wu W K K, Chung L, et al. Plasminogen Activator Inhibitor 1 for Predicting Sepsis
Severity and Mortality Outcomes: A Systematic Review and Meta-Analysis[J]. Front Immunol,
2018, 9: 1218. 10.3389/fimmu.2018.01218
[7] Nakayama T, Azegami T, Kiso M, et al. Plasminogen activator inhibitor 1 is not a major causative
factor for exacerbation in a mouse model of SARS-CoV-2 infection[J]. Sci Rep, 2023, 13(1): 3103.
10.1172/jci.insight.16604410.1038/s41598-023-30305-8
[8] 梁继芳, 王秀哲, 杨晓静, et al. 血栓弹力图最大血块强度值联合动脉血乳酸检测对老年
脓毒症患者预后的评估价值[J]. 中华老年医学杂志, 2022, 41(2): 168-172. 10.3760/ cma.j. issn.
0254-9026.2022.02.009
[9] Jiang X, Zhang C, Pan Y, et al. Effects of C-reactive protein trajectories of critically ill patients
with sepsis on in-hospital mortality rate[J]. Sci Rep, 2023, 13(1): 15223. 10.1038/s 41598-023-
42352-2
[10] Vago J P, Zaidan I, Perucci L O, et al. Plasmin and plasminogen prevent sepsis severity by
reducing neutrophil extracellular traps and systemic inflammation[J]. Int J Environ Res Public
Health, 2023, 8(8)10.3390/ijerph2006484610.1172/jci.insight.166044
[11] Woźnica-Niesobska E, Leśnik P. The Role of Plasminogen Activator Inhibitor 1 in Predicting
Sepsis-Associated Liver Dysfunction: An Observational Study[J]. 2023, 20(6)10.3390/ijerph
20064846
[12] 蔡雪蓉. 纤溶酶原激活物抑制剂-1 的研究进展[J]. 临床与病理杂志, 2020, 40(2): 458-463.
10.3978/j.issn.2095-6959.2020.02.032
[13] Mitev S, Topalova-Dimitrova A, Varlyakov A, et al. Acute mesenteric ischemia secondary to
superior mesenteric vein thrombosis in a patient with liver cirrhosis: A case report[J]. Medicine
(Baltimore), 2023, 102(32): e34549. 10.1097/md.0000000000034549
- 89 -